"Plasmapheresis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use.
| Descriptor ID |
D010956
|
| MeSH Number(s) |
E02.120.770 E02.912.715
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Plasmapheresis".
Below are MeSH descriptors whose meaning is more specific than "Plasmapheresis".
This graph shows the total number of publications written about "Plasmapheresis" by people in this website by year, and whether "Plasmapheresis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 1 | 2 |
| 2009 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 2 | 2 |
| 2015 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Plasmapheresis" by people in Profiles.
-
Trends in the use of therapeutic plasma exchange in multiple myeloma. J Clin Apher. 2020 Aug; 35(4):307-315.
-
Membrane-based therapeutic plasma exchange (mTPE): Technical and clinical experience. J Clin Apher. 2018 Feb; 33(1):38-45.
-
Thrombotic thrombocytopenic purpura in a postoperative patient taking cephalexin responding to plasmapheresis: A case report and review of cephalosporin-induced TTP. J Clin Apher. 2016 Oct; 31(5):473-5.
-
Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy. Transplantation. 2013 Oct 15; 96(7):649-56.
-
Severe lupus nephritis: the predictive value of a = 50% reduction in proteinuria at 6 months. Nephrol Dial Transplant. 2013 Sep; 28(9):2313-8.
-
Management of severe recurrent focal segmental glomerulosclerosis through circulating soluble urokinase receptor modification. Am J Ther. 2013 Mar-Apr; 20(2):226-9.
-
Complete remission in severe lupus nephritis: assessing the rate of loss in proteinuria. Nephrol Dial Transplant. 2012 Jul; 27(7):2813-9.
-
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med. 2011 Jul 31; 17(8):952-60.
-
Evidence of concurrent immunopathological mechanisms determining the pathology of severe lupus nephritis. Lupus. 2009 Feb; 18(2):149-58.
-
The prognosis and pathogenesis of severe lupus glomerulonephritis. Nephrol Dial Transplant. 2008 Apr; 23(4):1298-306.